Skip to main
NHP

NHP Stock Forecast & Price Target

NHP Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 14%
Buy 43%
Hold 43%
Sell 0%
Strong Sell 0%

Bulls say

National Healthcare is a strong healthcare real estate investment trust with a management team focused on strategic capital recycling to drive growth. With a solid portfolio and plans to increase their exposure to senior housing assets, the company has a strong potential for valuation improvement and achieving growth through acquisitions and dispositions. Despite potential risks and a recent lock-up expiration, NHP provides investors with a good opportunity to participate in the growing senior housing market.

Bears say

National Healthcare is highly dependent on its SHOP segment, which makes up the majority of revenue. However, with a concentrated portfolio in only a few regions and a higher emphasis on higher-acuity care, there is a limited organic growth outlook for the long term. Additionally, the company may struggle to access external capital in the future, and there are potential risks related to the pandemic and economic conditions in the regions where National Healthcare operates. These factors, combined with a potential difficulty in recycling capital through MOB sales, lead to a negative outlook for the stock.

NHP has been analyzed by 7 analysts, with a consensus rating of Buy. 14% of analysts recommend a Strong Buy, 43% recommend Buy, 43% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Healthcare Properties and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Healthcare Properties (NHP) Forecast

Analysts have given NHP a Buy based on their latest research and market trends.

According to 7 analysts, NHP has a Buy consensus rating as of Aug 2, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $17.14, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $17.14, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Healthcare Properties (NHP)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.